The U.S. government is close to a deal to acquire tens of millions of additional doses of Pfizer’s vaccine in exchange for helping the pharmaceutical giant gain better access to manufacturing supplies.

A person with knowledge of the negotiations told The Associated Press on Tuesday that the deal is under discussion and could be finalized shortly. The person spoke on condition of anonymity to describe ongoing deliberations.

Pfizer’s vaccine was the first to gain approval from the Food and Drug Administration and initial shipments went to states last week. It has now been joined by a vaccine from Moderna, which was developed in closer cooperation with scientists from the National Institutes of Health.

Moderna’s vaccine comes under the umbrella of the government’s own effort, which is called Operation Warp Speed. That public-private endeavor was designed to have millions of vaccine doses ready and available to ship once a shot received FDA approval.

But another deal with Pfizer would move the nation closer to the goal of vaccinating all Americans.

A law dating back to the Korean War gives the government authority to direct private companies to produce critical goods in times of national emergency. Called the Defense Production Act, it’s expected to be invoked to help Pfizer secure some raw materials needed for its vaccine.

Pfizer already has a contract to supply the government with 100 million doses of its vaccine under Operation Warp Speed, but government officials have said it’s more of an arms-length relationship with the company and they don’t have as much visibility into its operations.

Health and Human Services Secretary Alex Azar said last week that the government was negotiating with Pfizer for more doses, but details provided Tuesday about the company’s desire for better access to supplies are new.

Earlier, U.S. officials had said they were discussing the purchase of another 100 million doses of Pfizer vaccine for delivery as early as the middle of next year. Those details and timing may have changed.

Pfizer said in a statement that “we continue to work collaboratively with the U.S. government to get doses of our COVID-19 vaccine to as many Americans as possible. The company is not able to comment on any confidential discussions that may be taking place with the U.S. government.”

The vaccine from Pfizer and German pharmaceutical BioNTech immediately raised hopes of taming a pandemic that has killed nearly 320,000 people in the U.S. and hobbled much of the national economy. Health care workers and nursing home residents topped the list as local TV stations across the country began broadcasting scenes of the first vaccinations. Some polls show skepticism about getting vaccinated may be easing.

After early failures with testing, Trump administration officials are hoping to write a very different ending with vaccines. Operation Warp Speed has financed the development, manufacture and distribution of millions of doses, with the goal of providing a free vaccine to any American who wants one.

Operation Warp Speed is on track to have about 40 million doses of vaccine by the end of this month, of which about 20 million would be allocated for first vaccinations. Distribution of those doses would span into the first week of January. Both the Pfizer and Moderna vaccines require two shots to be fully effective.

The New York Times first reported the new details of negotiations between Pfizer and the Trump administration.

Photo via AP Photo/Bebeto Matthews.

Related Stories
‹
Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine
Written by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]
Pfizer, US Ink $5.29B Deal for Possible COVID-19 Treatment
Written by TOM MURPHY The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation’s largest purchase agreement yet for a coronavirus therapy. Pfizer asked the Food and Drug Administration on Tuesday to authorize emergency use of the experimental pill, which […]
U.S. Parents Excited Over Prospect of Virus Shots for Children
Written by HEATHER HOLLINGSWORTH and TODD RICHMOND After more than a year of fretting over her 13-year son with a rare liver disease, Heather Ousley broke into tears when she learned that he and millions of other youngsters could soon be eligible for the COVID-19 vaccine. “This day is the best day in the history of […]
'The Vaccine Couldn't Have Come at a Better Time': UNC Health Staff Receive First Doses
The UNC Medical Center in Chapel Hill was one of the first hospitals to receive the approved Pfizer vaccine to prevent COVID-19. With a shipment arriving Tuesday morning, hospital staff began vaccinating front line workers in the afternoon. Loc Culp is the nurse manager for the UNC Medical Center’s medical intensive care unit and said […]
‘Relieved’: U.S. Health Workers Start Getting COVID-19 Vaccine
The largest vaccination campaign in U.S. history got underway Monday as health workers in select hospitals rolled up their sleeves for shots to protect them from COVID-19 and start beating back the pandemic — a day of optimism even as the nation’s death toll neared 300,000. “I feel hopeful today. Relieved,” said critical case nurse […]
U.S. Allows Emergency COVID-19 Vaccine in Bid to End Pandemic
The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans. Shots for health workers and nursing home residents are expected to begin in the coming days after the Food and Drug Administration authorized an […]
U.S. Panel Endorses Widespread Use of Pfizer COVID-19 Vaccine
A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans. Shots could begin within days, depending on how quickly the Food and Drug Administration signs off, as expected, on […]
Pfizer COVID-19 Vaccine Faces Last Hurdle Before U.S. Decision
Pfizer’s COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags. Thursday’s meeting of the Food and Drug Administration’s vaccine advisory panel is likely the last step before a U.S. decision to begin […]
Pfizer: COVID-19 Shot 95% Effective, Seeking Clearance Soon
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — last data needed to seek emergency use of limited shot supplies even as the catastrophic outbreak worsens across the globe. The announcement from Pfizer and its German partner […]
Pfizer Says COVID-19 Vaccine Is Looking 90% Effective
Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration. The announcement, less than a week after a presidential election […]
›